Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation.
Ijaz A, Khan AY, Malik SU, Faridi W, Fraz MA, Usman M, Tariq MJ, Durer S, Durer C, Russ A, Parr NNC, Baig Z, Sagar F, Ali Z, McBride A, Anwer F.
Ijaz A, et al. Among authors: sagar f.
Biol Blood Marrow Transplant. 2019 Jan;25(1):94-99. doi: 10.1016/j.bbmt.2018.08.028. Epub 2018 Sep 6.
Biol Blood Marrow Transplant. 2019.
PMID: 30195074
Free PMC article.
Review.